All the Active Ingredient Drugs
Antipsychotic. Haloperidol 5 mg. TABS: 20, 25, 30 x 5 mg.
Moder. symptomatol ogy: 0.5-2 mg, 2
or 3 times dly.
Sev. symptomatology: 3-5 mg, 2 or 3
times dly. Geriat./ debilitated pts.:
0.5-2 mg, 2 or 3 times dly.
Chron./resist. pts.: 3-5 mg, 2 or 3 times
dly. Pts. who remain severely
disturbed or inadeq. control. may
require dosage adjust. Dly. dosages up
to 100 mg may be necessary in some
cases to achieve an optim. response.
Child. 3-12 yrs. (15-40 kg bdy. wt.) init.
dosage is 0.5 mg/day. If required,
dosage should be incr. by an increm.
of 0.5 mg at 5- to 7-day intervals, until
the desired ther. effect is achieved. The
total dosage may be admin. in divided
doses, 2-3 times dly.
Psychot. disords, tics, vocal utters. Of
Tourettes disord. in child and adult.
C/I: Comatose states, Hypersens, CNS
depress. due to alcohol/other
depressant drug. Parkinson’s dis.
Lesion of the basal ganglia. Pts. with
clinical.signific. card. disord. e.g. recent
acute MI, uncompens. heart fail.,
arrhythm. treated with class IA and III
antiarrhyth. med. products, QTc interv.
prolong., hist. of ventr. arrhyth.or
torsades de pointes clinical. signif.
bradycard., 2nd /3rd degree heart block
and uncorrected hypokalaemia.
Concom. use with other QT prolong.
drugs.
Antipsychotic. Haloperidol 5 mg/ml. Amp. Sol. for IM inj. 5 X 1 ml
Sev. ac. psychomotor agitat. assoc. with psychotic disord. or manic episodes of bipolar I disord. : 5 mg. May be repeat. hourly until suffic. sympt. ctrol is achieved.• In the major. of pts, doses of up to 15 mg/day are suffic. ,max. dose 20 mg/day. Tmt to be discontin. as soon as clin. indic. and, if further tmt is needed, oral haloperidol should be init. at a 1:1 dose convers. rate followed by dose adj. accord. to resp.
Ac. tmt. of delirium when non-pharmacol. tmts have failed:1 to 10 mg. Tmt. should start at lowest possible dose, and dose should be adjust. in incr. at 2- to 4-hour interv. if agit. continues, up to max. of 10 mg/d.
Tmt. of mild to moder. chorea in Huntington’s dis., when other drugs are ineffect. or not toler., and oral ther. is not appropr.: 2 to 5 mg. May be repeat. hourly until suffic. sympt. ctrol is achieved or up to max. of 10 mg/day.
Sgle or combinat. prophylaxis in pts at moder. - high risk of postoper. nausea and vomit, when other drugs are ineffect. or not toler.: 1 to 2 mg, at induct. or 30 mn before end of anaesthesia.
Combinat. tmt of postoper. nausea and vomit when other drugs are ineffect. or not toler:1 to 2 mg.
Indicated in adlt pts for:
• Rapid ctrol of sev ac. psychomotor agitat. assoc. with psychotic disord. or manic episodes of bipolar I disord. when oral ther. is not appropr.
• Ac. tmt. of delirium in ptt suffer. from sev. agitat. that may harm him, when non-pharmacol. tmts. have failed.
• Tmt. of mild to moder. chorea in Huntington’s dis., when other drugs are ineffect. or not toler., and oral ther. is not appropr.
• Sgle or combinat. prophylaxis in pts. at moder. to high risk of postoper. nausea and vomit, when other drugs are ineffect. or not toler.
• Combinat. tmt. of postoper. nausea and vomit. when other drugs are ineffect. or not toler.
C/I: Hypersens/Comatose state/
CNS depress./Parkinson/
Dementia with Lewy bodies/
Progress. supranuclear palsy/
QTc interval prolong. or congen. long QT syndr./
Recent ac. MI/
Uncompensated HF/
Hist. of ventric. arrhyth. or torsades de pointes/
Uncorrect. hypokalaemia/
Concomm. drugs that prolong QT interval
Antipsychotic. Haloperidol (as decanoate) 100 mg/ml. AMPS: 1, 5. 100 mg I.M. every 4 wks.
Once a mth. tmt. of ambulat. or hosp.
chron. schizophren.
Antipsychotic. Haloperidol 2 mg/ml. DROPPER BOTTLE: 15 ml, 30 ml (0.1 mg/
drop):
Adult.- Moder. symptomatology: 0.5-2
mg, 2/ 3 times dly.
Sev. symptomatology: 3-5 mg, 2 or 3
times dly.
Geriat. or debilitated pts.: 0.5-2 mg, 2
or 3 times dly.
Chron./resist. pts.: 3-5 mg, 2 or 3 times
dly. Pts. who remain severely disturbed
or inadeq. control. may require dosage
adjust. Dly. dosages up to 100 mg may
be necessary in some cases to achieve
an optim. response.
Child. 3-12 yrs.: (15-40 kg bdy. wt.) Init.
is 0.5 mg/day. If required, dosage
should be incr. by an increm. of 0.5 mg
at 5-7-day intervals, until the desired
therap. effect is achieved. The total
dosage may be admin. in divided
doses, 2-3 times dly.
Antipsychotic, psychomotor sedative. Addition., in pediatrics , for short-term tmt. of tics and vomit. (Gilles de la tourettes
syndr.).
C/I: Comatose states, Hypersens. CNS
depress. due to alcohol/other
depressant drug.
Parkinson’s dis. Lesion of the basal
ganglia. Pts. with clinical.signific. card.
disord. e.g. recent acute MI,
uncompens. heart fail., arrhythm.
treated with class IA and III antiarrhyth. med. products, QTc interv. prolong., hist. of ventr. arrhyth.or torsades de pointes clinical. signif. bradycard., 2nd
/3rd degree heart block and uncorrected hypokalaemia. Concom. use with other QT prolong. drugs.
Antipsychotic. Haloperidol 0.5, 5, 10 mg. TABS: 30 X 0.5 mg, 5 mg, 10 mg.
Managem. psychot. disords., control tics, vocal utters. of Tourettes disord. in child. and adlts. Dosage to be adjust. indiv. according to indication and its severity.
C/I: Hypersens, Comatose states, CNS depress. due to alcohol/other depressant drug. Parkinson’s dis., Lesion of the basal ganglia. Pts. with clinic. signific. card. disord. e.g. recent acute MI, uncompens. heart fail., arrhythm. treated with class IA and III antiarrhyth. med. products, QTc interv. prolong., hist. of ventr. arrhyth. or torsades de pointes, clinic. signif. bradycard., 2nd /3rd degree heart block and uncorrect. hypokalaemia. Concom. use with other QT prolong. drugs.
Antipsychotic. Haloperidol (as decanoate) 100 mg/ml. AMPS: 1, 5 x 100 mg/ml. 50-300 mg I.M.
every 4 wks. depend. on severity.
Initial: not greater than 100 mg.
Chron. schizophren. or other mental or
behav. problems which req. maint. tmt.
